{"disease":{"id":"myalgic-encephalomyelitis-chronic-fatigue-syndrome-me-cfs-icd-10-g93-3","name":"myalgic encephalomyelitis chronic fatigue syndrome me cfs icd 10 g93 3"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06731179","title":"A Prospective Study to Evaluate the Role of T-Cell Dysfunction in Patients Who Present Symptoms Associated With Long COVID, Lyme Disease and Myalic Encephalomyelitis / Chronic Fatigue Syndrome Using the Vira Immune Fluorospot T Cell Assay","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":160,"lead_sponsor_name":"ViraxBio Labs","has_results":false},{"nct_id":"NCT07317401","title":"Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) to Improve Fatigue, Pain, and Quality of Life by Targeting Mitochondrial Dysfunction and Autonomic Nervous System Impairment","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":104,"lead_sponsor_name":"University of Aarhus","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}